Press release
Oligonucleotide Delivery System Market Exclusive Report on Current Trends and Future Insights
The Global Oligonucleotide Delivery System Market is predicted to grow with a CAGR of 12.4% during the forecast period of 2024-2031.
Request for Sample Pages:
https://www.insightaceanalytic.com/request-sample/2779
The oligonucleotide delivery system market is amongst the most rapidly advancing fields within biotechnology and pharmaceuticals, as this deals with transporting oligonucleotide-based therapeutics to target cells. Oligonucleotides are short strands of nucleic acids that can be powerful for gene regulation and therapy. This drug has promising potential in treating several diseases, including genetic disorders, cancers, and infectious diseases. However, since these molecules are unstable and cannot easily penetrate the biological barriers, efficient delivery systems are crucial for these molecules to reach their site of action undamaged. These delivery systems significantly enhance the oligonucleotide's therapeutic efficiency and make them potential candidates for modern medicine.
Oligonucleotide delivery systems have varied applications in the treatment of genetic disorders, cancer diseases, infectious diseases, and neurological disorders. Other systems are conjugation-based ones, such as chemically conjugating oligonucleotides to carriers and nanoparticle-based systems for protection and transport; the viral vector-based direct delivery system, the exosome-based natural carriers, and liposome-based vesicles for enhanced stability. Such types of delivery technologies are needed to move ahead precise gene-targeting therapies. As researches go forward with more studies, a significant number of oligonucleotide-based treatments should be approved to provide additional treatment opportunities for complex diseases.
List of Prominent Players in the Oligonucleotide Delivery System Market:
• Biogen
• Sarepta Therapeutics, Inc.
• Jazz Pharmaceuticals plc
• Ionis Pharmaceuticals, Inc.
• Nippon Shinyaku Co., Ltd.
• AstraZeneca
• Alnylam Pharmaceuticals, Inc.
• Novartis AG
• Dicerna Pharmaceuticals, Inc. (Novo Nordisk)
• IVERIC bio, Inc. (Astellas Pharma Inc.)
• Elsie Biotechnologies (GSK)
Market Dynamics:
Drivers-
The oligonucleotide delivery system market is driven by a key set of factors. These are the increasing demands for targeted therapies, increasing efficiencies in delivery technologies, approvals gained at the regulatory levels, and the growing incidence of genetic disorders and cancer. In this respect, personalized medicine would be one of the major driving needs for oligonucleotide-based treatments such as antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs), which require effective delivery systems. Advances in nanoparticle-based systems, viral vectors, and conjugation strategies continue to enhance the stability, uptake, and targeting of the therapies. The emergence of new drugs with approval from regulators, including ONPATTRO and GIVLAARI, has restored confidence in the technologies, leading to increased investments. Rising incidence of genetic disorders and cancer and associated R&D investments favor market growth.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2779
Challenges:
Delivery systems for oligonucleotides currently experience problems related to low efficiency, stability, targeting, and safety. Oligonucleotides do not easily cross biological barriers, resulting in their frequent degradation that also impacts the therapeutic efficiency of a particular therapy. Precise targeting to tissue sites is challenging, so it is still common to have off-targeting complications, while, additionally, the development of immune responses with the risk of immunogenicity and safety problems poses further challenges. Solutions to such problems are indispensable for further developing oligonucleotide-based therapies.
Regional Trends:
North America is dominating the oligonucleotide delivery system market, followed by Europe and Asia. The dominance of this oligonucleotide delivery system market is attributed to developed research infrastructure, more investments in life sciences, a supportive regulatory environment, and increased incidence of genetic disorders. An innovative biotechnology company network with the presence of research institutions and universities creates an encouraging environment for developing oligonucleotide-based therapies in the region. High investment in personalized therapeutic systems along with favorable FDA support for oligonucleotide-based drugs spurs growth in the oligonucleotide delivery system market. The rising incidence of genetic disorders and cancers requires successful treatments, and market leaders, such as Biogen, Alnylam Pharmaceuticals, and Ionis Pharmaceuticals, have already established a foothold in this region.
Recent Developments:
• In April 2024, Nippon Shinyaku Co., Ltd has announced a joint research agreement with MiNA Therapeutics to develop nucleic acid medicines targeting intractable and rare diseases in the central nervous system.
• In July 2023, Novartis has announced the acquisition of DTx Pharma, a preclinical-stage biotechnology company based in San Diego, which specializes in using its proprietary FALCON platform to develop siRNA therapies for neuroscience applications.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/2779
Segmentation of Oligonucleotide Delivery System Market-
Oligonucleotide Delivery System Market- By Delivery System
• Conjugation-Based Delivery Systems
o GALNAc Conjugation
o Ligand Conjugation
o Antibody Conjugation
o Targeting Moiety Conjugation
• Nanoparticle-Based Delivery Systems
o Lipid Nanoparticles (LNPs)
o Peptide Nanoparticles
• Viral Vector-Based Delivery Systems
o Adeno-associated Virus (AAV) Vectors
o AAV9
o Lentiviral Vectors
o Others
• Exosome-Based Delivery Systems
• Liposomes
• Others
Oligonucleotide Delivery System Market- By Disease Indication
• Genetic Disorders
• Infectious Diseases
• Oncology
• Neurological Disorders
• Others (Autoimmune Diseases, Metabolic Disorders, etc.)
Oligonucleotide Delivery System Market- By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Get more information: @
https://www.insightaceanalytic.com/report/oligonucleotide-delivery-system-market/2779
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oligonucleotide Delivery System Market Exclusive Report on Current Trends and Future Insights here
News-ID: 3839698 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
4PL Logistics Market Revenue Report with Forecast to 2034
"4PL Logistics Market" in terms of revenue was estimated to be worth $59.6 Billion in 2024 and is poised to reach $133.3 Billion by 2034, growing at a CAGR of 8.5% from 2025 to 2034 according to a new report by InsightAce Analytic.
Get Free Sample Report @
https://www.insightaceanalytic.com/request-sample/1609
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global 4PL Logistics Market are:
• Rapid growth of automotive the…
Heavy-Duty Autonomous Vehicle Market Exclusive Trends Analysis with Forecast to …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Heavy-Duty Autonomous Vehicle Market- (By Application (Logistics, Public Transportation, Construction and Mining, Others), By Propulsion Type (Internal Combustion Engine Vehicles, Electric Vehicles), By Vehicle Type (Heavy Trucks, Heavy Buses, Roboshuttles), By Level of Autonomy (Fully Autonomous Vehicles, Semi-Autonomous Vehicles), By Sensor Type (LiDAR, RADAR, Camera, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According…
E-Commerce Logistics Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-Commerce Logistics Market Size, Share & Trends Analysis Report By Service Type (Transportation And Warehousing) And Operational Area (International And Domestic)- Market Outlook And Industry Analysis 2034"
The global e-commerce logistics market is estimated to reach over USD 5340.2 billion by 2034, exhibiting a CAGR of 26.4% during the forecast period.
Request For Free Sample Pages:…
E-bikes Market Exclusive Report on the Latest Revenue and Future Scope
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-bikes Market Size, Share & Trends Analysis Report By Class (Class-I, Class-II, Class-III), Speed (Up to 25km/h, 25-45 km/h), Battery Type (Lithium-ion, Lithium-ion Polymer, Lead Acid), Mode (Pedal Assist, Throttle), Component (batteries, electric motors, frames with forks, wheels, crank gears, brake systems and motor controllers) , Motor Type (hub and mid), Usage (mountain, trekking, city/urban,…
More Releases for Delivery
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Last Mile Delivery: Your Fast Track to Delivery Efficiency
The importance of last-mile logistics has increased significantly in recent years due to the rapid growth of e-commerce, evolving consumer demands, and the necessity for efficient and timely deliveries. Covid-19 has also played a part in hastening the rise of last-mile deliveries. In logistics, 'first-mile' and 'last-mile' delivery are terms used to describe the movement of goods within the supply chain. The first leg of the supply chain journey commences…
Smart Drug Delivery Systems Market: Revolutionizing Healthcare Delivery
In a rapidly evolving landscape of healthcare, smart drug delivery systems (SDDS) have emerged as a transformative force, catering to the increasing demand for advanced treatment solutions. According to a recent report, the global smart drug delivery systems market was valued at a staggering US$ 8.7 billion in 2022, with projections indicating a remarkable CAGR of 15.2% from 2022 to 2031. By the end of this forecast period, the market…
Revolutionizing Last-Mile Delivery: The Growing Delivery Robots Market
"According to the research report, the global delivery robots market was valued at USD 148.07 million in 2022 and is expected to reach USD 2,148.92 million by 2032, to grow at a CAGR of 30.7% during the forecast period."
Polaris Market Research has recently published the latest update on Delivery Robots Market: By Size, Latest Trends, Share, Huge Growth, Segments, Analysis and Forecast, 2030 that offers detailed market analysis, encompassing its…
Nasal Drug Delivery Market - Effortless Delivery, Optimal Results: Nasal Drug De …
Newark, New Castle, USA - new report, titled Nasal Drug Delivery Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Nasal Drug Delivery market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Nasal Drug Delivery market. The report offers an overview of…
Telemedicine Market Report 2022 by Mode of Delivery, End User, Region-Cloud base …
The Telemedicine market will reach US$ 387.7 Mn by 2028 - Persistence Market Research (PMR), a well-known name in market research.
The current scenario is such that people and healthcare professionals are increasingly preferring virtual consulting due its low costs and effective treatment. This scenario is, by all means, favoring the Telemedicine market growth.
The forecast period (2022-2028) will see North America scale greater heights in the Telemedicine market. This is basically…
